Malaria

GSK’s malaria vaccine gets WHO okay for mass rollout

The WHO has given a green light to widespread use of GlaxoSmithKline’s malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine – also known as Mosquirix – will be administered to children living in sub-Saharan Africa and other regions with moderate to high …

GSK’s malaria vaccine gets WHO okay for mass rollout Read More »

WHO endorses use of world’s first malaria vaccine in Africa

World Health Organization’s director general hails ‘historic day’ in fight against parasitic disease The World Health Organization has recommended the widespread rollout of the first malaria vaccine, in a move experts hope could save tens of thousands of children’s lives each year across Africa. Hailing “an historic day”, the WHO’s director general, Dr Tedros Adhanom …

WHO endorses use of world’s first malaria vaccine in Africa Read More »

Novartis drug raises hope of tackling malaria drug resistance

More than two decades ago , Novartis made a big contribution to the fight against malaria when it won approval for Coartem, the first artemisinin-based combination therapy (ACT), which has transformed care for people with the parasitic infection. Now – over a billion doses of Coartem (artemether-lumefantrine) later – the drugmaker thinks it may have …

Novartis drug raises hope of tackling malaria drug resistance Read More »

More malaria hope as antibody protects against infection

A single dose of a monoclonal antibody developed by scientists at the US National Institutes of Health (NIH) has provided protection for people exposed to malaria parasites for up to nine months. The results of the phase 1 trial suggest that antibodies could be used to protect travellers, military personnel and health care workers traveling …

More malaria hope as antibody protects against infection Read More »

BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022

Shots: BioNTech unveils the plan to develop the first mRNA-based vaccine to prevent malaria with anticipated initiation of the clinical study by the end of 2022 The company intends to set up a large vaccine production hub in Africa with the help of local partners and transfer its mRNA technology to Africa. These efforts of …

BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022 Read More »

BioNTech’s mRNA vaccine drive now includes malaria, TB shots

Flushed with the success of its COVID-19 vaccine, BioNTech has pressed the accelerator on the development of shots for other infectious diseases, and now plans to take malaria and tuberculosis candidates into the clinic next year. Human testing of the malaria shot should get underway by the end of 2022, according to the German biotech, …

BioNTech’s mRNA vaccine drive now includes malaria, TB shots Read More »

Insect Repellents

Date:  July 12, 2021 Issue #:  1628 Summary:  The Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) recommend using insect repellents to prevent infections transmitted by mosquitoes and ticks. Insect repellents applied to exposed skin should be used in conjunction with other preventive measures such as wearing pants and long-sleeved …

Insect Repellents Read More »

Breaking Down the U.S. Global Health Budget by Program Area

The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program area: HIV/PEPFAR; tuberculosis (TB); malaria/the President’s Malaria Initiative (PMI); the Global Fund to Fight AIDS, Tuberculosis, and Malaria; maternal & child health (MCH); nutrition; family planning & reproductive health (FP/RH); …

Breaking Down the U.S. Global Health Budget by Program Area Read More »

Oxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacy

Following the success of the coronavirus vaccine developed with AstraZeneca, Oxford University’s Jenner Institute has unveiled trial results showing its experimental malaria shot could be around 77% effective. There is a malaria vaccine on the market – GlaxoSmithKline’s Mosquirix – but this is only around 39% effective in young children and has not been backed …

Oxford’s malaria shot set for phase 3 test after ‘unprecedented’ 77% efficacy Read More »

Fever Benefits for Autism in a Food

Dramatic improvements in children with autism when they have a fever suggest that the disorder may be reversible if one can replicate the phenomenon in other ways. Autism currently affects about 1 in 68 kids in the United States, yet we don’t even have drugs to treat the core symptoms, never mind the underlying disorder itself. …

Fever Benefits for Autism in a Food Read More »

Will fighting COVID-19 disrupt progress against malaria?

That is the key question explored in a recent article from The Economist titled “Masked up, ready to battle bugs“. As individuals in developing nations leave crowded cities for fear of COVID, they may be at more risk for malaria due to the presence of more standing water (which attracts malarial mosquitos) used for irrigation …

Will fighting COVID-19 disrupt progress against malaria? Read More »